<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00430989</url>
  </required_header>
  <id_info>
    <org_study_id>6/07</org_study_id>
    <nct_id>NCT00430989</nct_id>
  </id_info>
  <brief_title>The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial</brief_title>
  <official_title>Large, Randomised, Parallel-group, Controlled Trial, With Patients Randomly Allocated to Either N2O-containing (70% N2O in Oxygen [FiO2 0.3]) or N2O-free (70% Nitrogen in Oxygen [FiO2 0.3]).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayside Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Health and Medical Research Council, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bayside Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the safety of nitrous oxide (N2O) anaesthesia in patients with risk factors
      for coronary artery disease undergoing major surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 25% of patients undergoing major surgery have known coronary artery disease
      (CAD) or risk factors for CAD.

      N2O interferes with vitamin B12 and folate metabolism. This impairs production of methionine
      (from homocysteine), used to form tetrahydrofolate and thymidine during DNA synthesis. It has
      been repeatedly demonstrated that N2O anaesthesia increases postoperative homocysteine
      levels. Chronic hyperhomocysteinaemia is associated with cardiovascular disease, and acute
      hyperhomocysteinaemia is known to cause endothelial dysfunction. One small trial has
      demonstrated an increased incidence of postoperative myocardial ischaemia in patients
      receiving N2O anaesthesia. Reducing postoperative myocardial infarction and death are
      important aims for those with CAD undergoing major surgery.

      Our previous trial (ENIGMA) studied 2050 patients and identified some serious adverse
      effects, but most patients were not at risk of CAD and so we could not reliably assess
      serious cardiac complications. We propose a large simple randomized clinical trial of 7,000
      patients to provide a definitive evaluation of the safety of N2O anaesthesia.

      Updated statistical analysis plan can be found at www.enigma2.org.au.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>international, randomised, assessor-blinded trial in patients aged at least 45 years with known or suspected coronary artery disease having major non-cardiac surgery.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>The treating anaesthetist will be unblinded to the allocation. All other personnel (surgeon, participant and outcome assessor are all blinded to treatment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary Endpoint is a Composite of Death and Cardiovascular Events (Clinical and Silent MI, Cardiac Failure, Cardiac Arrest, Pulmonary Embolism, and Stroke) Measured at 30 Days After Surgery.</measure>
    <time_frame>30 days post op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction (MI)</measure>
    <time_frame>30 days post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Arrest</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary Embolism</measure>
    <time_frame>30 Days Post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>30 Days Post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound Infection</measure>
    <time_frame>30 Days Post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay (Days)</measure>
    <time_frame>30 Days Post Op</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7112</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>70% Nitrous Oxide</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>General anaesthesia using 70% Nitrous Oxide with fraction of inspired oxygen at 30%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Nitrous Oxide</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>General anaesthesia not containing Nitrous oxide with fraction of inspired oxygen at 30%</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nitrous Oxide</intervention_name>
    <description>General anaesthesia with the inclusion of Nitrous Oxide at 70%</description>
    <arm_group_label>70% Nitrous Oxide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Nitrous Oxide</intervention_name>
    <description>General anaesthesia with no use of Nitrous Oxide</description>
    <arm_group_label>No Nitrous Oxide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Adult males and females age ≥ 45 years, undergoing noncardiac surgery and general
             anaesthesia expected to exceed two hours.

          2. At increased risk of cardiac events, defined as any of

               1. history of coronary artery disease as defined by a history of any one of the
                  following: i. angina ii. MI iii. segmental wall motion abnormality on
                  echocardiography or a fixed defect on radionuclide imaging iv. a positive
                  exercise stress test for cardiac ischaemia v. a positive radionuclide exercise,
                  echocardiographic exercise, or pharmacological cardiovascular stress test for
                  cardiac ischaemia vi. coronary revascularization (CABG or PTCA) vii. angiographic
                  evidence of atherosclerotic stenosis &gt; 50% of the diameter of any coronary artery
                  viii. ECG with pathological Q waves in two contiguous leads

               2. heart failure

               3. cerebrovascular disease thought due to atherothrombotic disease

               4. aortic or peripheral vascular disease

               5. or three or more of the following risk factors:

                    -  age ≥70 years

                    -  any history of congestive heart failure

                    -  diabetes and currently on an oral hypoglycaemic agent or insulin therapy

                    -  current treatment for hypertension

                    -  preoperative serum creatinine &gt;175 micro mol/L (&gt; 2.0 mg/dl)

                    -  current or previous high cholesterol ≥6.2 mmol/L (&gt; 240 mg/dl)

                    -  history of a transient ischemic attack (TIA) (i.e. a transient focal
                       neurological deficit that lasted less than 24 hours and thought to be
                       vascular in origin)

                    -  emergency/urgent surgery (i.e. surgery which must be undertaken within 24
                       hours of acute presentation to hospital)

                    -  high-risk type of surgery (i.e. intrathoracic or intraperitoneal)

        Exclusion Criteria

          1. having cardiac surgery

          2. marked impairment of gas-exchange expected to require Fi02&gt; 0.5 intraoperatively

          3. specific circumstances where N2O is contraindicated (eg. volvulus, pulmonary
             hypertension, raised intracranial pressure) or the anaesthetist plans to use
             supplemental oxygen (eg. colorectal surgery)

          4. N2O unavailable for use.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul S Myles, MBBS MPH MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Alfred</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alfred Hosptial</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <link>
    <url>http://www.enigma2.org.au</url>
    <description>Related Info</description>
  </link>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>January 31, 2007</study_first_submitted>
  <study_first_submitted_qc>February 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2007</study_first_posted>
  <results_first_submitted>February 16, 2016</results_first_submitted>
  <results_first_submitted_qc>March 18, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 17, 2019</results_first_posted>
  <last_update_submitted>November 24, 2019</last_update_submitted>
  <last_update_submitted_qc>November 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anaesthesia</keyword>
  <keyword>Major Surgery</keyword>
  <keyword>Coronary artery disease</keyword>
  <keyword>Nitrous oxide</keyword>
  <keyword>Effects of Nitrous Oxide following Anaesthesia</keyword>
  <keyword>Anaesthesia and coronary artery disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Nitrous Oxide Group</title>
          <description>General anaesthesia containing Nitrous oxide and fraction of inspired oxygen of 30%</description>
        </group>
        <group group_id="P2">
          <title>No Nitrous Oxide</title>
          <description>General anaesthesia not containing Nitrous oxide with fraction of inspired oxygen of 30%</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3543"/>
                <participants group_id="P2" count="3569"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3483"/>
                <participants group_id="P2" count="3509"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not eligible</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Of 10 102 eligible patients, 7112 patients were enrolled and randomly assigned: 3543 to receive nitrous oxide and 3569 not to receive nitrous oxide; 7011 patients underwent induction of anaesthesia and were included at baseline, and 6992 patients were assessed for the primary endpoint (figure 1).</population>
      <group_list>
        <group group_id="B1">
          <title>N2O Group (FiO2 0.3)</title>
          <description>Nitrous Oxide as an inspired concentration of 70% in 30% Oxygen</description>
        </group>
        <group group_id="B2">
          <title>N2O Free Group (FiO2 0.3)</title>
          <description>Nitrous Oxide free air and inspired Oxygen concentration of 30%</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3495"/>
            <count group_id="B2" value="3516"/>
            <count group_id="B3" value="7011"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>AGE&gt;18</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.2" spread="9.8"/>
                    <measurement group_id="B2" value="69.5" spread="9.7"/>
                    <measurement group_id="B3" value="69.3" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1253"/>
                    <measurement group_id="B2" value="1299"/>
                    <measurement group_id="B3" value="2552"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2242"/>
                    <measurement group_id="B2" value="2217"/>
                    <measurement group_id="B3" value="4459"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="706"/>
                    <measurement group_id="B2" value="701"/>
                    <measurement group_id="B3" value="1407"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2587"/>
                    <measurement group_id="B2" value="2630"/>
                    <measurement group_id="B3" value="5217"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indian/Pakistani</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Primary Endpoint is a Composite of Death and Cardiovascular Events (Clinical and Silent MI, Cardiac Failure, Cardiac Arrest, Pulmonary Embolism, and Stroke) Measured at 30 Days After Surgery.</title>
        <time_frame>30 days post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrous Oxide: 70% N2O (FiO2 0.3)</title>
            <description>N2O Group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
          <group group_id="O2">
            <title>N2O Free Group (FiO2 0.3)</title>
            <description>N2O free group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
        </group_list>
        <measure>
          <title>The Primary Endpoint is a Composite of Death and Cardiovascular Events (Clinical and Silent MI, Cardiac Failure, Cardiac Arrest, Pulmonary Embolism, and Stroke) Measured at 30 Days After Surgery.</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3483"/>
                <count group_id="O2" value="3509"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="283"/>
                    <measurement group_id="O2" value="296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Myocardial Infarction (MI)</title>
        <time_frame>30 days post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrous Oxide: 70% N2O (FiO2 0.3)</title>
            <description>N2O Group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
          <group group_id="O2">
            <title>N2O Free Group (FiO2 0.3)</title>
            <description>N2O free group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
        </group_list>
        <measure>
          <title>Myocardial Infarction (MI)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3483"/>
                <count group_id="O2" value="3509"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="215"/>
                    <measurement group_id="O2" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Arrest</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrous Oxide: 70% N2O (FiO2 0.3)</title>
            <description>N2O Group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
          <group group_id="O2">
            <title>N2O Free Group (FiO2 0.3)</title>
            <description>N2O free group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Arrest</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3483"/>
                <count group_id="O2" value="3509"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pulmonary Embolism</title>
        <time_frame>30 Days Post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>N2O Group (FiO2 0.3)</title>
            <description>N2O Group (FiO2 0.3)</description>
          </group>
          <group group_id="O2">
            <title>N2O Free Group (FiO2 0.3)</title>
            <description>N2O free group (FiO2 0.3)</description>
          </group>
        </group_list>
        <measure>
          <title>Pulmonary Embolism</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3483"/>
                <count group_id="O2" value="3509"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stroke</title>
        <time_frame>30 Days Post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrous Oxide: 70% N2O (FiO2 0.3)</title>
            <description>N2O Group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
          <group group_id="O2">
            <title>N2O Free Group (FiO2 0.3)</title>
            <description>N2O free group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
        </group_list>
        <measure>
          <title>Stroke</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3483"/>
                <count group_id="O2" value="3509"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wound Infection</title>
        <time_frame>30 Days Post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrous Oxide: 70% N2O (FiO2 0.3)</title>
            <description>N2O Group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
          <group group_id="O2">
            <title>N2O Free Group (FiO2 0.3)</title>
            <description>N2O free group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
        </group_list>
        <measure>
          <title>Wound Infection</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3483"/>
                <count group_id="O2" value="3509"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="321"/>
                    <measurement group_id="O2" value="311"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Stay (Days)</title>
        <time_frame>30 Days Post Op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrous Oxide: 70% N2O (FiO2 0.3)</title>
            <description>N2O Group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
          <group group_id="O2">
            <title>N2O Free Group (FiO2 0.3)</title>
            <description>N2O free group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
Nitrous Oxide: N2O 70% v's No N2O</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Stay (Days)</title>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3483"/>
                <count group_id="O2" value="3509"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" lower_limit="3.3" upper_limit="10"/>
                    <measurement group_id="O2" value="6.1" lower_limit="3.3" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 Days</time_frame>
      <desc>Adverse events do not include the primary endpoint variables</desc>
      <group_list>
        <group group_id="E1">
          <title>Nitrous Oxide: 70% N2O</title>
          <description>N2O Group (FiO2 0.3)
Nitrous Oxide: 70% N2O V's No N2O
General anaesthesia containing Nitrous oxide and fraction of inspired oxygen of 30%</description>
        </group>
        <group group_id="E2">
          <title>Nitrous Oxide Free</title>
          <description>Nitrous Oxide free group (FiO2 0.3)
Nitrous Oxide: N2O 70% v's No N2O
General anaesthesia not containing Nitrous oxide and fraction of inspired oxygen of 30%</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="3483"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="3509"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="283" subjects_at_risk="3483"/>
                <counts group_id="E2" subjects_affected="296" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="3483"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="215" subjects_affected="215" subjects_at_risk="3483"/>
                <counts group_id="E2" events="219" subjects_affected="219" subjects_at_risk="3509"/>
              </event>
              <event>
                <sub_title>Cariac Arrest</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3483"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="42" subjects_affected="42" subjects_at_risk="3483"/>
                <counts group_id="E2" events="57" subjects_affected="57" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="3483"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="662" subjects_at_risk="3483"/>
                <counts group_id="E2" subjects_affected="546" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding complications</sub_title>
                <counts group_id="E1" events="54" subjects_affected="54" subjects_at_risk="3483"/>
                <counts group_id="E2" events="56" subjects_affected="56" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular</sub_title>
                <counts group_id="E1" events="90" subjects_affected="90" subjects_at_risk="3483"/>
                <counts group_id="E2" events="25" subjects_affected="25" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" events="106" subjects_affected="106" subjects_at_risk="3483"/>
                <counts group_id="E2" events="85" subjects_affected="85" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Other</sub_title>
                <description>All other events less than 2% overall</description>
                <counts group_id="E1" events="134" subjects_affected="134" subjects_at_risk="3483"/>
                <counts group_id="E2" events="128" subjects_affected="128" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurological</sub_title>
                <counts group_id="E1" events="53" subjects_affected="53" subjects_at_risk="3483"/>
                <counts group_id="E2" events="48" subjects_affected="48" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urology</sub_title>
                <counts group_id="E1" events="72" subjects_affected="72" subjects_at_risk="3483"/>
                <counts group_id="E2" events="73" subjects_affected="73" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory</sub_title>
                <counts group_id="E1" events="103" subjects_affected="103" subjects_at_risk="3483"/>
                <counts group_id="E2" events="93" subjects_affected="93" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular</sub_title>
                <counts group_id="E1" events="50" subjects_affected="50" subjects_at_risk="3483"/>
                <counts group_id="E2" events="38" subjects_affected="38" subjects_at_risk="3509"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>All 'other' adverse events the events were classed according to system MedDRA reporting and not by individual event.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Professor Paul Myles</name_or_title>
      <organization>Bayside health</organization>
      <phone>+61390762000 ext 3176</phone>
      <email>p.myles@alfred.org.au</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

